在患有多发性骨髓瘤的患者中,B细胞成熟抗原仿制抗原受体-T疗法缓解了心力衰竭

Yunhong Wang1, Ke Zhang2, Xiaohui Suo3

  • 1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ESC heart failure
|November 1, 2023
PubMed
概括

针对B细胞成熟抗原 (BCMA) 的化学抗原受体 (CAR) -T细胞疗法对多发性骨髓瘤 (MM) 是有前途的. 这种疗法成功地治疗了由于轻链心脏粉症导致的严重心力衰竭的患者.